Hasil Pencarian - Anneli Nilsson
- Menampilkan 1 - 4 hasil dari 4
-
1
566 ATOR-1017, a second generation 4–1BB antibody with potential to enhance efficacy of PD-1 therapies oleh Karin Enell Smith, Peter Ellmark, Anneli Nilsson
Diterbitkan 2021-11-01Artikel -
2
851 Potent tumor-directed T cell activation and in vivo tumor inhibition induced by a 4–1BB x 5T4 ADAPTIR™ bispecific antibody oleh Sara Fritzell, Michelle Nelson, Robert Miller, Catherine McMahan, David Bienvenue, Gabriela Hernandez-Hoyos, Anneli Nilsson, Lill Ljung, Allison Chunyk, Maria Askmyr
Diterbitkan 2020-11-01Artikel -
3
837 Combination treatment with ATOR-4066, a Neo-X-Prime™ bispecific antibody targeting CD40 and CEACAM5, and anti-PD-1 reverses T cell exhaustion in vitro oleh Malin Lindstedt, Peter Ellmark, Karin Hägerbrand, Sara Fritzell, Anette Sundstedt, David Gomez Jimenez, Anneli Nilsson, Lill Ljung, Mattias Levin, Mona Celander, Ida Uddbäck, Amulya Krishna Shetty, Hampus Andersson
Diterbitkan 2023-11-01Artikel -
4
796 ALG.APV-527: a 5T4 tumor directed bispecific approach utilizing ADAPTIRTM technology designed for conditional 4-1BB T cell/NK agonism against solid tumors oleh Peter Ellmark, Anette Sundstedt, Lena Schultz, Michelle Nelson, Jane Gross, Catherine McMahan, Anneli Nilsson, Lill Ljung, Allison Chunyk, Ashly Lucas, Hilario Ramos, Yago Pico de Coaña, Sara Frizell
Diterbitkan 2021-11-01Artikel